Pharmacy board of australia guidelines

These also help to clarify the Board ’s views and expectations on a range of issues. The National Boards regulating registered health. Guidelines for advertising regulated health services. Specifically, the use of titles may be misleading into believing that the practitioner is a psychiatrist when they are not.

The products outlined on this page assist in meeting your board requirements and are available for purchase through the PSA’s online shop. It is responsible for administration of the Act which provides for the regulation of pharmacy businesses. The pharmacist who is regularly and usually in charge of a pharmacy or pharmacy department: 1. PSA’s Professional Practice Standards (PPS) articulate the values of the pharmacy profession and expected standards of professional behaviour of pharmacists towards individuals, the community and society.

There is no information on or any specific mention of pharmacy or dispensary assistants. Extracts from the relevant acts are summarised below. One of the key issues reviewed was Dose Administration Aids (DAAs), with new guidelines released. AHPRA Choose a National Board website Contact us Office locations. At this time, the applicant must show how the business satisfies requirements for registration including any regulations, standards or guidelines.

Each health profession that is part of the National Registration and Accreditation Scheme is represented by a National Board. Australian Health Practitioner Regulation Agency. While the primary role of the Boards is to protect the public, the Boards are also responsible for registering practitioners and students, as well as other functions, for their professions.

The Board’s guidelines are for practitioners and students who perform exposure-prone procedures and registered health practitioners who are treating registered health practitioners or students living with a blood-borne virus who perform exposure-prone procedures. Cancer Council guidelines. All Boards are supported by AHPRA in the framework of a Health Profession Agreement. National Boards delegated some of their decision making powers to national committees, state and territory boards or to AHPRA. Continuing Professional Development (CPD) is the means by which pharmacists continue to maintain, improve and broaden their knowledge, expertise and competence, and develop the personal and professional qualities required throughout their professional lives.

Do you have any suggestions for questions to be included in the Board’s FAQ for pharmacists on the compounding of medicines, to support pharmacists in their understanding and application of this guidance? Safety and quality guidelines for nurse practitioners. Advertising a regulated health service. Read the PSA My Health Record guidelines.

This format for presentation of technical documentation will significantly reduce the time and resources needed to compile applications for registration of pharmaceuticals and will in future ease the preparation of electronic submissions. VPP assists applicants with meeting inspection requirements and allows for the distribution of necessary information to the boards where a new or renewed license is being sought. Pharmacy and Poisons Board. State and Territory Medical Board Members. At a minimum, a pharmacist’s professional obligations with respect to pharmaceutical compounding should be determined with reference to all publications listed above.

Innovator pharmaceutical product: Means a pharmaceutical product, which was first authorized for marketing (normally as a patented product) on the basis of documentation of efficacy, safety and quality (according to the requirements at the time of authorization). Overview of legislative framework. Rationale and design of a randomized trial to evaluate an evidence-based prescription drug label on actual medication use.

Position statements.